Drug said to be effective against early migraine symptoms
May 14 (UPI) -- Migraines don't just cause headaches. These attacks often are accompanied by symptoms like light and sound sensitivity, nausea, neck pain and dizziness.
What's more, those non-headache symptoms tend to crop up before a full-fledged migraine headache takes root.
But now, researchers say they've discovered an already approved migraine drug that can stop these other symptoms hours before a headache starts.
Ubrogepant successfully warded off early migraine symptoms in patients who took the drug one to six hours before a headache, causing a 72% increased likelihood a person wouldn't experience light sensitivity and an 85% increased likelihood they wouldn't have fatigue.
Doubled likelihood they wouldn't experience neck pain or sound sensitivity.
The drug also helped people think and concentrate better despite their oncoming migraine, researchers reported Monday in Nature Medicine.
The results suggest that ubrogepant could "free patients from a disabling part of migraine," study co-author Dr. Peter Goadsby, a neuroscientist at King's College London, told Nature.
Ubrogepant gained approval from the U.S. Food and Drug Administration in 2019 after studies showed that it reduced headache pain and other migraine symptoms within two hours of taking the pill, according to Drugs.com.
The drug works by blocking a protein involved in pain and migraines called calcitonin gene-related peptide, or CGRP. Ubrogepant prevents the CGRP protein from attaching to nerve endings.
Symptoms that occur prior to a migraine are called "prodome" symptoms. Migraines occur when a brain region called the hypothalamus goes out of whack, and these prodomal symptoms precede the headache.
"Not enough attention has been given to prodrome symptoms," Goadsby said, noting that the new study was mean to "fill this gap."
For the study, researchers recruited 438 people who could reliably predict oncoming migraine attacks based on their prodomal symptoms.
People were randomly assigned to take either ubrogepant or a placebo just before a migraine attack and keep notes on their symptoms.
They then waited for their next migraine and took the opposite treatment, be it the medicine or placebo. Participants didn't know what they were taking either time.
Patients taking Ubrogepant reported:
• Better ability to concentrate within an hour
• Reduced light sensitivity within two hours
• Reduced fatigue and neck pain after three hours
• Reduced sound sensitivity after four hours
However, it is essential that people take the drug before their headache if they want to stop these other symptoms, Goadsby said.
"People who know their migraine would benefit more from this medicine," he said, arguing that doctors should train patients to detect early migraine symptoms so they can judge when to take ubrogepant.
More information
Cleveland Clinic has more on migraines.
Copyright © 2025 HealthDay. All rights reserved.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Ispace Resilience moon lander scheduled for afternoon touchdown
June 5 (UPI) -- Privately owned Japanese aerospace company ispace on Thursday will make its second attempt to land a remotely controlled capsule on the moon as part of its settlement effort. The uncrewed ispace Resilience moon lander is scheduled to touch down on the moon at 3:17 EDT on Thursday, but the landing time would change if its landing location does, too. A SpaceX Falcon 9 rocket on Jan. 15 launched the ispace lander to the moon along with a private Blue Ghost moon lander built by Firefly Aerospace, reported. The Blue Ghost touched down on the Mare Crisium region of the moon on March 2. The Resilience mission took much longer to reach the moon due to a low-energy transfer path that ispace chose for its lander, which arrived in orbit around the moon on May 6. The Resilience is scheduled to land on the moon's Mare Figoris region, which is located on the near side of the moon's northern hemisphere. The about 7.5-foot-tall lander contains a four-wheeled rover named Tenacious for exploring the lunar surface in the moon's unexplored northern region. The rover contains a high-definition camera, a shovel for collecting lunar samples for NASA and weighs about 11 pounds. It also contains a tiny red cottage that its builder, Mikael Genberg, named the Moonhouse, which the rover will place on the moon's surface. The Resilience also might land on one of three secondary locations on the moon if the primary landing spot isn't feasible, which would postpone its landing to another day. If the primary landing spot is available, the touchdown is scheduled to be streamed live starting at 2:20 p.m. EDT on the ispace YouTube channel. The livestream will be presented in English, but another livestream is available in Japanese. A similar ispace mission in April 2023 failed when its uncrewed lander crashed while trying to land in the moon's Atlas Crater. It was ispace's first attempt to put a lander on the moon. The mission is part of ispace's plan to colonize the moon by having people living on it by 2040, ABC News reported. The privately owned aerospace firm intends to build a city housing 1,000 people and would host thousands more who could visit as tourists. Officials at ispace also plan to land a much larger lander on the moon with assistance from NASA. That mission is scheduled to launch by 2027.
Yahoo
2 hours ago
- Yahoo
USDA: Organic ground beef sold at Whole Foods may be contaminated with E. coli
June 5 (UPI) -- Some packages of organic ground beef sold at Whole Foods stores across the country may be contaminated with E. coli, federal officials have warned. The U.S. Department of Agriculture's Food Safety and Inspection Service issued a public health alert Wednesday about 1-pound packages of "Organic Rancher Organic Ground Beef 85% lean, 15% fat." The affected beef was produced May 22 and 23, 2025, and has "Use or Freeze By 06-19-25" or "Use or Freeze By 06-20-25" printed on the label. The packaging also includes the establishment number "EST. 4027" inside the USDA mark of inspection, CBS News reported. While this beef is no longer being sold in stores, officials say some may still be in customers' homes. Anyone with this product should not eat it. "These products should be thrown away or returned to the place of purchase," the alert stated. The ground beef was sold at Whole Foods Market locations nationwide and also sent to distributors in Connecticut, Georgia, Illinois and Maryland. No illnesses have been reported yet, but the USDA is urging caution because E. coli is a "potentially deadly bacterium" that can cause dehydration, abdominal cramps and bloody diarrhea. "While most people recover within a week, some develop a type of kidney failure called hemolytic uremic syndrome," the alert said. "This condition can occur among persons of any age but is most common in children under 5 years old and older adults," it added. "It is marked by easy bruising, pallor and decreased urine output. Persons who experience these symptoms should seek emergency medical care immediately." More information Read the full health alert from the USDA Food Safety & Inspection Service. Copyright © 2025 HealthDay. All rights reserved.
Yahoo
5 hours ago
- Yahoo
Watch: Creatures escape in spaceship crash in 'Alien: Earth'
June 5 (UPI) -- FX and Hulu released the first full-length trailer for the eagerly awaited Alien: Earth series on Thursday. The sci-fi show is set to premiere on Aug. 12. Noah Hawley is its creator, executive producer and director. The Alien prequel will star Sydney Chandler, Timothy Olyphant, Alex Lawther, Samuel Blenkin, Babou Ceesay, Adrian Edmondson, David Rysdahl, Essie Davis, Lily Newmark, Erana James, Adarsh Gourav, Jonathan Ajayi, Kit Young, Diêm Camille, Moe Bar-El and Sandra Yi Sencindiver. "In the year 2120, the Earth is governed by five corporations: Prodigy, Weyland-Yutani, Lynch, Dynamic and Threshold. In this Corporate Era, cyborgs (humans with both biological and artificial parts) and synthetics (humanoid robots with artificial intelligence) exist alongside humans," a synopsis released in May said. Thursday's 2-minute preview showed the residents of the futuristic Neverland Research Island facility on Earth trying to find and neutralize the predatory alien monsters who escaped in a space ship crash. Many of the characters share names with those that appear in the classic fairy tale Peter Pan, such as Wendy, Nibs, Tootles, Slightly and Smee.
